The multifaceted role of KIF15 in cancer progression and therapy

Sarah Qutayba Badraldin1, Karar H Alfarttoosi2, Hayder Naji Sameer3

  • 1College of Pharmacy, Alnoor University, Nineveh, Iraq.

PubMed

Insights

Kinesin family member 15 (KIF15) drives cancer progression and metastasis. Inhibiting KIF15 offers a promising therapeutic strategy to restrict tumor growth and improve cancer treatment outcomes.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Kinesin family member 15 (KIF15) is a motor protein vital for cell division.
  • Aberrant KIF15 expression is linked to cancer onset, promoting proliferation, migration, and invasion.
  • KIF15's role in oncogenic pathways extends beyond cell mechanics.

Purpose of the Study:

  • To review the multifaceted roles of KIF15 in cancer biology.
  • To highlight KIF15's regulatory functions and interactions with cancer-related signaling pathways.
  • To explore KIF15 as a potential therapeutic target in oncology.

Main Methods:

  • Literature review of KIF15 research in cancer biology.
  • Analysis of KIF15's involvement in cell cycle regulation and tumorigenesis.
  • Evaluation of KIF15 as a target for cancer therapeutics.

Main Results:

  • KIF15 significantly influences cancer cell proliferation, migration, and metastasis.
  • KIF15 interacts with key signaling pathways critical for tumor development.
  • Elevated KIF15 levels in cancers present a therapeutic vulnerability.

Conclusions:

  • KIF15 is crucial for both cell division and cancer progression.
  • Targeting KIF15 offers a promising avenue for novel cancer therapies.
  • Further research is essential for developing effective KIF15-targeted treatments.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K